June 20 (Reuters) - AstraZeneca PLC:

* TRUQAP PLUS FASLODEX APPROVED IN EU FOR PATIENTS WITH ADVANCED ER-POSITIVE BREAST CANCER Source text for Eikon: Further company coverage: